Back
Regeneron Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$777.05
Seasonality Move:
3.11%
7 Day Trial
ALL ACCESS PASS
$
7
Regeneron Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 31.1% based on the past 35 years of stock performance.
-
Regeneron Pharmaceuticals, Inc. has risen higher in 20 of those 35 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Regeneron Pharmaceuticals, Inc. Stock Undervalued?The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $772.64. The Score for REGN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 31.1% based on the past 35 years of stock performance.
Regeneron Pharmaceuticals, Inc. Stock Rating
Buy
56
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. overpriced?
-
Regeneron Pharmaceuticals, Inc. has risen higher in 20 of those 35 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Regeneron Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
821.11
52-Week Low:
476.49
Prediction Charts
Market Cap:
81.7B
Price in USD:
772.64
Volume:
642.7K
Beta:
0.93
Technical Analysis
SMA50:
764.38
SMA100:
752.80
SMA200:
660.28
52-Wk Change:
21.82%
Stock Predictions
-
Is Regeneron Pharmaceuticals, Inc. stock public?Yes, Regeneron Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Regeneron Pharmaceuticals, Inc. stock quote today?The Regeneron Pharmaceuticals, Inc. stock price is 772.64 USD today.
-
How to buy Regeneron Pharmaceuticals, Inc. stock online?You can buy Regeneron Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-12 | 764.06 | 746.61 | 766.00 | 744.00 |
| Mar-13 | 754.55 | 745.77 | 758.98 | 741.90 |
| Mar-16 | 750.00 | 756.91 | 763.30 | 747.01 |
| Mar-17 | 763.53 | 759.05 | 771.23 | 755.64 |
| Mar-18 | 751.22 | 744.12 | 757.60 | 734.56 |
| Mar-19 | 744.50 | 737.45 | 750.32 | 727.88 |
| Mar-20 | 738.17 | 732.87 | 744.85 | 728.64 |
| Mar-23 | 745.00 | 736.53 | 750.00 | 735.00 |
| Mar-24 | 728.51 | 741.69 | 743.17 | 727.96 |
| Mar-25 | 745.00 | 749.47 | 757.98 | 744.02 |
| Mar-26 | 749.40 | 756.73 | 761.73 | 747.77 |
| Mar-27 | 756.65 | 737.71 | 759.47 | 736.64 |
| Mar-30 | 743.83 | 749.29 | 757.68 | 741.47 |
| Mar-31 | 757.47 | 772.64 | 774.26 | 755.80 |
Regeneron Pharmaceuticals, Inc. Earnings
Regeneron Pharmaceuticals, Inc. Earnings Report: Per Share Regeneron Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals, Inc. Forecast Revenue Growth
Regeneron Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $3.99 per share, a decrease next quarter of $0.56 per share, an increase this year of $1.64 per share, and an increase next year of $7.62 per share.
* Regeneron Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.